Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PIT565 |
Trade Name | |
Synonyms | PIT-565|PIT 565 |
Drug Descriptions |
PIT565 is a trispecific antibody that targets CD19 expressed on tumor cells, and CD3 and CD2 expressed on T-lymphocytes, potentially leading to tumor cell killing and antitumor activity (Blood (2022) 140 (Supplement 1): 3148). |
DrugClasses | CD19 Antibody 21 CD3 Antibody 99 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
PIT565 | PIT565 | 0 | 1 |